We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YARW
726
Yarrow Bioscience, Inc. Common Stock
YARW
$20.3M
| $694K | 0.01% |
116
+50
| +76% | +$292K |
|
727
Dycom Industries
DY
$11.2B
| $692K | 0.01% |
13,109
| – | – |
|
|
RPAI
728
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $692K | 0.01% |
119,104
-396,978
| -77% | -$2.55M |
|
729
Belden
BDC
$3.97B
| $690K | 0.01% |
22,180
+8,843
| +66% | +$291K |
|
|
WPX
730
DELISTED
WPX Energy, Inc.
WPX
| $686K | 0.01% |
+139,980
| New | +$775K |
|
|
DZSI
731
DELISTED
DZS Inc. Common Stock
DZSI
| $682K | 0.01% |
72,797
-3,435
| -5% | -$34.5K |
|
|
ELVT
732
DELISTED
Elevate Credit, Inc.
ELVT
| $680K | 0.01% |
264,530
-3,192
| -1% | -$6.77K |
|
|
NOVA
733
DELISTED
Sunnova Energy
NOVA
| $670K | 0.01% |
+22,024
| New | +$522K |
|
734
Rocky Brands
RCKY
$368M
| $666K | 0.01% |
26,830
-3,568
| -12% | -$81K |
|
|
CPRX
735
DELISTED
Catalyst Pharmaceutical
CPRX
| $665K | 0.01% |
224,074
-19,576
| -8% | -$76.6K |
|
|
MORF
736
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $664K | 0.01% |
24,295
+6,273
| +35% | +$164K |
|
737
Edgewell Personal Care
EPC
$1.3B
| $662K | 0.01% |
23,727
-2,529
| -10% | -$75K |
|
738
Triumph Financial Inc
TFIN
$1.81B
| $660K | 0.01% |
21,201
-14,833
| -41% | -$406K |
|
|
GMS
739
DELISTED
GMS Inc
GMS
| $658K | 0.01% |
+27,304
| New | +$669K |
|
|
SCTL
740
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $652K | 0.01% |
310,630
-8,529
| -3% | -$28K |
|
741
Seres Therapeutics
MCRB
$45M
| $646K | 0.01% |
1,141
-10,624
| -90% | -$3.53M |
|
|
SBBP
742
DELISTED
Strongbridge Biopharma plc.
SBBP
| $646K | 0.01% |
307,613
-17,671
| -5% | -$59.6K |
|
743
ServiceNow
NOW
$120B
| $641K | 0.01% |
6,610
| – | – |
|
744
Kiniksa Pharmaceuticals
KNSA
$6.31B
| $640K | 0.01% |
41,780
-3,377
| -7% | -$63.4K |
|
|
MGI
745
DELISTED
MoneyGram International, Inc. New
MGI
| $639K | 0.01% |
+226,154
| New | +$711K |
|
746
Haverty Furniture Companies
HVT
$418M
| $638K | 0.01% |
30,445
+2,571
| +9% | +$46.6K |
|
747
Amdocs
DOX
$6.03B
| $629K | 0.01% |
+10,964
| New | +$655K |
|
748
RBB Bancorp
RBB
$448M
| $629K | 0.01% |
55,457
-10,696
| -16% | -$136K |
|
|
WBA
749
DELISTED
Walgreens Boots Alliance
WBA
| $626K | 0.01% |
17,423
-21,528
| -55% | -$842K |
|
750
HBT Financial
HBT
$1.33B
| $625K | 0.01% |
55,722
-20,690
| -27% | -$253K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.